Kalvista Pharmaceuticals Inc (KALV)

Currency in USD
12.41
-0.25(-1.97%)
Closed·
After Hours
12.65+0.24(+1.93%)
·

KALV Financial Summary

Key Ratios

P/E Ratio-4.17
Price/Book8.03
Debt / Equity117.61%
Return on Equity-121.5%
Dividend Yield0.00%
EBITDA-187.05M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2016
30/04
2017
30/04
2018
30/04
2019
30/04
2020
30/04
2021
30/04
2022
30/04
2023
30/04
2024
30/04
2025
30/04
* In Millions of USD (except for per share items)

Analyst Ratings

10 Buy
0 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 31.67
(+155.17% Upside)

Earnings

Latest Release
Jul 10, 2025
EPS / Forecast
-0.99 / -0.8489
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What was Kalvista Pharma's net income for the latest quarter?

Kalvista Pharma's net income for the latest quarter was -52.23.

How does Kalvista Pharma's debt to equity ratio compare to industry standards?

Kalvista Pharma's total debt-to-equity ratio is 117.61%.

What is Kalvista Pharma's return on investment on a TTM basis?

Kalvista Pharma's trailing twelve months (TTM) return on investment (ROI) is -121.50%.

Did Kalvista Pharma gain or lose cash last quarter?

In the latest quarter, Kalvista Pharma's net change in cash was -35.67 million.

What were Kalvista Pharma's total assets and liabilities in the latest quarter?

As of the latest quarter, Kalvista Pharma reported total assets of 250.77 million and total liabilities of 45.17 million.

What was Kalvista Pharma's revenue per share for the latest quarter?

Kalvista Pharma's revenue per share for the latest quarter was 3.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.